Biotech · Private company · Baltimore, MD, US
Origin Endoscopy Inc.
Track this companyFree. Adds Origin Endoscopy Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- Development of EpiMAX, a first-in-class injectable hemostatic agent for long-acting hemostasis of gastrointestinal bleedingFiscal year 2026 · $1.2MNIH RePORTER 1R44DK145328-01A1 · fetched Nov 12, 2026